Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reissue Patent
2007-06-21
2010-12-28
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S242000, C544S320000, C544S321000
Reissue Patent
active
RE042015
ABSTRACT:
The present invention is directed to a compound, method and composition of treating or preventing viral infections, in particular, human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infections, in human patients or other animal hosts, comprising the administration of N4-acylcytosine-1,3-dioxolane and pharmaceutically acceptable salts, prodrugs, and other derivatives thereof.
REFERENCES:
patent: 4522811 (1985-06-01), Eppstein
patent: 4957924 (1990-09-01), Beauchamp
patent: 5561120 (1996-10-01), Lin
patent: 5703058 (1997-12-01), Schinazi
patent: 5905070 (1999-05-01), Schinazi
patent: 5922867 (1999-07-01), Mansour
patent: 6232300 (2001-05-01), Schinazi
patent: 6350753 (2002-02-01), Belleau et al.
patent: 2003/0013660 (2003-01-01), Attardo
patent: 99493 (1984-01-01), None
patent: 409 227 (1989-05-01), None
patent: 8901258 (1991-01-01), None
Bacheler Lt., et al. (1994), An assay for HIV RNIn infected cell lysates, and its use for rapid evaluation of antiviral efficacy. Antivir. Chem. Chemother. 5:111-121.
Charvet, A.S., et al., (1994), Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate- an phosphonoacetate-2′,3′-dideoxy-3′-thiacytidine conjugates, J. Med. Chem., 37:2216-2223.
Chou T., et al., Adv. Enzyme Regul., 1984, 22, 27-55.
Glubis, et al., (1993), Structure of dideoxynucleside active against the HIV (AIDS) virus, Acta Cryst. C49, 1095-1097, N4-isopropyl-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine.
Hosteller, K.Y., et al., Greatly enhanced inhibition of human immunodeficiency virus type 1 replication in CEM and HT4-6C cells by 3′-deoxythymidine diphosphate dimyristoylglycerol, a lipid prodrug of 3′-deoxythymidine, Antimicrob. Agents Chemother., 1992, 36, 2025-2029.
Hosteller, K.Y., et al., Synthesis and antiretroviral activity of phospholipid analogs of azidothymidine and other antiviral nucleosides, J. Biol. Chem., 1990, 265, 61127.
Jadhav, P.K., et al., (1997), Cyclic urea amide: HIV-1 protease inhibitors with low nanomolar potency against both wild types and protease inhibitor resistant mutants of HIV J. Med. Chem. 40:181-190.
Kawaguchi, et al., Studies on 2′,3′-dideoxy-2′,3′-didehydropyrimidine nucleosides, II. N4-benzoyl-2′,3′-diddeoxy-2′,3′-didehydrocytidine as a prodrug of 2′,3′-didehydrocytidine (DDCN), Chem. Pharm. Bull. (1989), 37(9), 2547-9, N4-benzoyl-2′3′-dideoxycytidine.
Kucera, L.S., et al., Novel membrane-interactive ether lipid analogs that inhibit infectious HIV-1 production and induce defective virus formation, AIDS Res. Hum. Retroviruses, 1990, 6, 491-501.
Ladner, S.K., et al., Antimicro. Agents Chemother., 1997, 41, 1715-1720.
Mauldin, et al., (1998), Synthesis and antiviral activity of prodrugs of the nucleoside 1-[2′,3′-dideoxy-3′-C-(hydroxymethyl)-B-D-erythropentofuranosyl] cytosine, Bioorg. Med. Chem., 6, 577-585.
Plantadosi, C., et al., Synthesis and evaluation of novel ether lipid nucleoside conjugates for anti-HIV activity, J. Med. Chem., 1991, 34, 1408-1414.
Schinazi, R.F., et al., Antimicrob. Agents Chemother., 1992, 36, 2423.
Schinazi, R.F., et al., Antimicrob. Agents Chemother., 1990, 34, 1061-1067.
Shi, et al., (1999), Synthesis and biological evaluation of 2′,3′-dideoxy-5-fluorocytidine (d4FC) analogues: discovery of carbocyclic nucleoside triphosphates with potent inhibitory activity against HIV-1 reverse transcriptase, J. Med. Chem., 42, 859-867.
Wolff, Burger's Medicinal Chemistry, 5ed, Part I, John Wiley & Sons, 1995, pp. 975-977.
Banker, et al., Modern Pharmaceutics, 3ed, Marcel Dekker, New York, 1996, pp. 451 and 596.
Kim, et al., Journal of Medicinal Chemistry, 36(5), 519-28 (English) 1993.
Lee, et al., Bioorganic & Medicinal Chemistry Letters, 5(17), 2011-14 (English) 1995.
Otto Michael J.
Shi Junxing
Watanabe Kyoichi A.
Merchant & Gould P,C,
Pharmasset, Inc.
Rao Deepak
LandOfFree
N4-acylcytosine-1,3-dioxolane nucleosides for treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N4-acylcytosine-1,3-dioxolane nucleosides for treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N4-acylcytosine-1,3-dioxolane nucleosides for treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4156930